Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study

计划入组 1,300 人 · 首次发布于 2025 年 4 月 20 日

Prediction of Atrial Fibrillation Using Polygenic Risk Score

计划入组 800 人 · 首次发布于 2026 年 6 月 11 日

Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure

计划入组 300 人 · 首次发布于 2025 年 5 月 8 日

GS-4774

Tamoxifen(Soltamox)

C₂₆H₂₉NO · Rx

Raloxifene(Evista, Optruma, Raloxifene Teva)

C₂₈H₂₇NO₄S · Rx

ADVANTAGE RISK MANAGEMENT CO., LTD.

Japan

TWG HEALTH RISK MANAGEMENT (PTY) LTD

South Africa

NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH

United States

Pervasive Gene–Environment Interactions Reshape Polygenic Risk Score Utility Across Exposures

Allelica Partners with Mass General Brigham for PROACT 3 Trial Testing Polygenic Risk Score Impact on Cardiovascular Prevention

Genetic Risk Score Predicts Blood Pressure Response to Chlorthalidone in Black Individuals